medigraphic.com
Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular

2016, Number 3

<< Back Next >>

Rev Mex Angiol 2016; 44 (3)

Estenosis en venas centrales en el paciente renal en hemodiálisis; relación de su aparición a través de marcadores biológicos

Ríos-Gómez R, Cruz-Cruz VM, Salazar-Flores CA, Laparra-Escareño H, Fuentes-Quezada JJ, Vázquez-García S, Serrano-Lozano JA

Language: Spanish
References: 16
Page: 93-98
PDF size: 121.04 Kb.


ABSTRACT

Background. The prevalence of superior vena cava syndrome secondary to venous stenosis or thrombosis after placement of hemodialysis catheters ranging in rank from 10 to 50%. No specific studies of biological markers as risk factor for preventing the occurrence of venous central stenosis. However, numerous studies have documented hypoalbuminemia as a marker of endothelial damage.
Objective. To demonstrate the relationship between hypoalbuminemia and the appearance of central stenosis in patients with chronic renal failure undergoing placement of a central venous catheter for hemodialysis replacement therapy.
Material and methods. The type of study is retrospective, transversal, analytical, observational conducted by the Vascular Surgery Service of Hospital “Lic. Adolfo López Mateos”, ISSSTE.
Results. Regarding the puncture site for the placement of central venous catheter between both jugular veins and the emergence of venous central stenosis is statistically significant between the two sites (SD 1.55 ± 0.475 P ‹ 0.05) in relation to the number of catheters (SD 1.29 55 ± 0.475 P ‹ 0.05).
Conclusions. With the study we suspect that all patients with chronic renal failure and the presence of central venous catheter for hemodialysis should be ruled central stenosis through extension studies, with the aim of reducing the early vascular access failure.


REFERENCES

  1. Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: a modern management strategy. Clin Oncol 1997; 9: 83-9.

  2. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123-33.

  3. Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001; 286: 700-7.

  4. Agarwal AK, Patel BM, Haddad NJ. Central vein stenosis: a nephrologist’s perspective. Semin Dial 2007; 20: 53-62.

  5. Kohler TR, Kirkman TR. Central venous catheter failure is induced by injury and can be prevented by stabilizing the catheter tip. J Vasc Surg 1998; 28: 59-66.

  6. Hernández D, Díaz F, Rufino M, Lorenzo V, Pérez T, Rodríguez A, et al. Subclavian vascular access stenosis in dialysis patients: natural history and risk factors. J Am Soc Nephrol 1998; 9: 1507-10.

  7. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991; 6: 722-4.

  8. Salgado OJ, Urdaneta B, Colmenares B, Garcia R, Flores C. Right versus left internal jugular vein catheterization for hemodialysis: complications and impact on ipsilateral access creation. Artif Organs 2004; 28: 728-33.

  9. Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 2005; 13: 325-31.

  10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-36.

  11. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barr P, Cartier P, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-34.

  12. Ordonez JD, Hiatt R, Killebrew E, Fireman B. The increased risk of coronary artery disease associated with nephrotic syndrome. Kidney Int 1993; 37: 638- 42.

  13. Pickart LR, Thaler MM. Free fatty acids and albumin as mediators of thrombin-stimulated fibrinogen synthesis. Am J Physiol 1976; 230: 996-1002.

  14. Kim SB, Yang WS, Chi HS, Park JS. Effect of increasing serum albumin on plasma D-dimer and von Willebrand factor levels and platelet aggregation in CAPD patients. Am J Kidney Dis 1999; 33: 312-7.

  15. Marcus AJ. Platelet activation. In: Fuster V, Ross R, Topol EJ (eds.). Atherosclerosis and Coronary Artery Disease. 1st ed. Philadelphia: Lippincott-Raven; 1996, pp. 607-37.

  16. Stephen ET, Peter AR. Central vein stenosis an Asian hemodialysis population. Asian cardiovascular & Thracici Annals 2012; 20(5): 560-5.




2020     |     www.medigraphic.com